A direct role for Met endocytosis in tumorigenesis

Nature Cell Biology

Volumn 13, Issue 7, 2011, Pages 827-837

  Joffre, Carine ^a,c   Barrow, Rachel ^a   Ménard, Ludovic ^a   Calleja, Véronique ^b   Hart, Ian R ^a   Kermorgant, Stéphanie ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

5 (2,6 DICHLOROBENZYLSULFONYL) 3 [3,5 DIMETHYL 4 [2 (1 PYRROLIDINYLMETHYL) 1 PYRROLIDINYLCARBONYL] 1H PYRROL 2 YLMETHYLENE] 1,3 DIHYDRO 2H INDOL 2 ONE; ACTIN; CBL PROTEIN; CLATHRIN; DYNAMIN; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; RAC1 PROTEIN; SCATTER FACTOR RECEPTOR;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CARCINOGENICITY; CELL MIGRATION; CELL STRAIN 3T3; CONTROLLED STUDY; CYTOSKELETON; ENDOCYTOSIS; ENDOSOME; ENZYME ACTIVATION; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN METABOLISM; SIGNAL TRANSDUCTION; SOLID TUMOR; STRESS FIBER;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CLATHRIN; DYNAMINS; ENDOCYTOSIS; ENDOSOMES; ENZYME ACTIVATION; FEMALE; GRB2 ADAPTOR PROTEIN; HUMANS; LUNG NEOPLASMS; MICE; MICE, NUDE; MUTATION; NEOPLASM INVASIVENESS; NIH 3T3 CELLS; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-CBL; PROTO-ONCOGENE PROTEINS C-MET; RAC1 GTP-BINDING PROTEIN; RECEPTORS, GROWTH FACTOR; RECOMBINANT FUSION PROTEINS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SOFT TISSUE NEOPLASMS; STRESS FIBERS; TIME FACTORS; TRANSFECTION; TUMOR BURDEN;

EID: 79959999334     PISSN: 14657392     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/ncb2257     Document Type: Article

References (57)

1. Teis, D., Wunderlich, W. & Huber, L. A. Localization of the MP1-MAPK scaffold complex to endosomes is mediated by p14 and required for signal transduction. Dev. Cell 3, 803-814 (2002). (Pubitemid 35460781)
2. Palamidessi, A. et al. Endocytic trafficking of Rac is required for the spatial restriction of signaling in cell migration. Cell 134, 135-147 (2008). (Pubitemid 351905741)
3. Schenck, A. et al. The endosomal protein Appl1 mediates Akt substrate specificity and cell survival in vertebrate development. Cell 133, 486-497 (2008). (Pubitemid 351608689)
4. McPherson, P. S., Kay, B. K. & Hussain, N. K. Signaling on the endocytic pathway. Traffic 2, 375-384 (2001). (Pubitemid 32574004)
5. Kermorgant, S., Zicha, D. & Parker, P. J. PKC controls HGF-dependent c-Met Traffic, signalling and cell migration. EMBO J. 23, 3721-3734 (2004). (Pubitemid 39389704)
6. Miaczynska, M., Pelkmans, L. & Zerial, M. Not just a sink: endosomes in control of signal transduction. Curr. Opin. Cell Biol. 16, 400-406 (2004). (Pubitemid 38903146)
7. Kermorgant, S. & Parker, P. J. Receptor trafficking controls weak signal delivery: a strategy used by c-Met for STAT3 nuclear accumulation. J. Cell Biol. 182, 855-863 (2008).
8. Sorkin, A., McClure, M., Huang, F. & Carter, R. Interaction of EGF receptor and grb2 in living cells visualized by fluorescence resonance energy transfer (FRET) microscopy. Curr. Biol. 10, 1395-1398 (2000).
9. Vieira, A. V., Lamaze, C. & Schmid, S. L. Control of EGF receptor signaling by clathrin-mediated endocytosis. Science 274, 2086-2089 (1996). (Pubitemid 27020702)
10. Howe, C. L., Valletta, J. S., Rusnak, A. S. & Mobley, W. C. NGF signaling from clathrin-coated vesicles: evidence that signaling endosomes serve as a platform for the Ras-MAPK pathway. Neuron 32, 801-814 (2001). (Pubitemid 34024842)
11. Le Roy, C. & Wrana, J. L. Signaling and endocytosis: a team effort for cell migration. Dev. Cell 9, 167-168 (2005). (Pubitemid 41051734)
12. Polo, S. & Di Fiore, P. P. Endocytosis conducts the cell signaling orchestra. Cell 124, 897-900 (2006). (Pubitemid 43344231)
13. von Zastrow, M. & Sorkin, A. Signaling on the endocytic pathway. Curr. Opin. Cell Biol. 19, 436-445 (2007). (Pubitemid 47287673)
14. Kermorgant, S. & Parker, P. J. c-Met signalling: spatio-temporal decisions. Cell Cycle 4, 352-355 (2005).
15. Gould, G. W. & Lippincott-Schwartz, J. New roles for endosomes: from vesicular carriers to multi-purpose platforms. Nat. Rev. Mol. Cell Biol. 10, 287-292 (2009).
16. Jekely, G., Sung, H. H., Luque, C. M. & Rorth, P. Regulators of endocytosis maintain localized receptor tyrosine kinase signaling in guided migration. Dev. Cell 9, 197-207 (2005). (Pubitemid 41051739)
17. Wang, Y., Pennock, S., Chen, X. & Wang, Z. Endosomal signaling of epidermal growth factor receptor stimulates signal transduction pathways leading to cell survival. Mol. Cell Biol. 22, 7279-7290 (2002).
18. Kholodenko, B. N. Cell-signalling dynamics in time and space. Nat. Rev. Mol. Cell Biol. 7, 165-176 (2006).
19. Lanzetti, L. & Di Fiore, P. P. Endocytosis and cancer: an ̀insider' network with dangerous liaisons. Traffic 9, 2011-2021 (2008).
20. Mosesson, Y., Mills, G. B. & Yarden, Y. Derailed endocytosis: an emerging feature of cancer. Nat. Rev. Cancer 8, 835-850 (2008).
21. Rao, D. S. et al. Altered receptor trafficking in Huntingtin Interacting Protein 1-transformed cells. Cancer Cell 3, 471-482 (2003). (Pubitemid 38340294)
22. Comoglio, P. M. Pathway specificity for Met signalling. Nat. Cell Biol. 3, E161-E162 (2001). (Pubitemid 32624413)
23. Birchmeier, C., Birchmeier, W., Gherardi, E. & Vande Woude, G. F. Met, metastasis, motility and more. Nat. Rev. Mol. Cell Biol. 4, 915-925 (2003). (Pubitemid 37493640)
24. Christensen, J. G., Burrows, J. & Salgia, R. c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention. Cancer Lett. 225, 1-26 (2005). (Pubitemid 40732764)
25. Schmidt, L. et al. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat. Genet. 16, 68-73 (1997). (Pubitemid 27198158)
26. Jeffers, M. et al. Activating mutations for the met tyrosine kinase receptor in human cancer. Proc. Natl Acad. Sci. USA 94, 11445-11450 (1997). (Pubitemid 27451018)
27. Bardelli, A. et al. Uncoupling signal transducers from oncogenic MET mutants abrogates cell transformation and inhibits invasive growth. Proc. Natl Acad. Sci. USA 95, 14379-14383 (1998). (Pubitemid 28549375)
28. Graveel, C. R., London, C. A. & Vande Woude, G. F. A mouse model of activating met mutations. Cell Cycle 4, 518-520 (2005). (Pubitemid 41359769)
29. Gampel, A. et al. VEGF regulates the mobilisation of VEGFR-2/KDR from an intracellular endothelial storage compartment. Blood 108, 2624-2631 (2006).
30. Kermorgant, S., Zicha, D. & Parker, P. J. Protein kinase C controls microtubule-based Traffic but not proteasomal degradation of c-Met. J. Biol. Chem. 278, 28921-28929 (2003). (Pubitemid 36935802)
31. Kirchhausen, T., Macia, E. & Pelish, H. E. Use of dynasore, the small molecule inhibitor of dynamin, in the regulation of endocytosis. Methods Enzymol. 438, 77-93 (2008).
32. Hill, T. A. et al. Inhibition of dynamin mediated endocytosis by the dynoles synthesis and functional activity of a family of indoles. J. Med. Chem. 52, 3762-3773 (2009).
33. Li, N., Lorinczi, M., Ireton, K. & Elferink, L. A. Specific Grb2-mediated interactions regulate clathrin-dependent endocytosis of the cMet-tyrosine kinase. J. Biol. Chem. 282, 16764-16775 (2007). (Pubitemid 47093241)
34. Sorkin, A. & von Zastrow, M. Endocytosis and signalling: intertwining molecular networks. Nat. Rev. Mol. Cell Biol. 10, 609-622 (2009).
35. Shtiegman, K. et al. Defective ubiquitinylation of EGFR mutants of lung cancer confers prolonged signaling. Oncogene 26, 6968-6978 (2007). (Pubitemid 350014608)
36. Nakaigawa, N., Weirich, G., Schmidt, L. & Zbar, B. Tumorigenesis mediated by MET mutant M1268T is inhibited by dominant-negative Src. Oncogene 19, 2996-3002 (2000). (Pubitemid 30389090)
37. Ponzetto, C. et al. Specific uncoupling of GRB2 from the Met receptor. Differential effects on transformation and motility. J. Biol. Chem. 271, 14119-14123 (1996).
38. Egan, S. E. et al. Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature 363, 45-51 (1993). (Pubitemid 23144959)
39. Heasman, S. J. & Ridley, A. J. Mammalian Rho GTPases: new insights into their functions from in vivo studies. Nat. Rev. Mol. Cell Biol. 9, 690-701 (2008).
40. Miller, M. et al. Structural basis of oncogenic activation caused by point mutations in the kinase domain of the MET proto-oncogene: modeling studies. Proteins 44, 32-43 (2001). (Pubitemid 32510582)
41. Xiang, Z., Kreisel, F., Cain, J., Colson, A. & Tomasson, M. H. Neoplasia driven by mutant c-KIT is mediated by intracellular, not plasma membrane, receptor signalling. Mol. Cell Biol. 27, 267-282 (2007). (Pubitemid 46013250)
42. Runeberg-Roos, P., Virtanen, H. & Saarma, M. RET(MEN 2B) is active in the endoplasmic reticulum before reaching the cell surface. Oncogene 26, 7909-7915 (2007). (Pubitemid 350261786)
43. Lievens, P. M., Mutinelli, C., Baynes, D. & Liboi, E. The kinase activity of-broblast growth factor receptor 3 with activation loop mutations affects receptor trafficking and signaling. J. Biol. Chem. 279, 43254-43260 (2004).
44. Choudhary, C. et al. Mislocalized activation of oncogenic RTKs switches downstream signaling outcomes. Mol. Cell 36, 326-339 (2009).
45. Schmidt-Arras, D. et al. Anchoring of FLT3 in the endoplasmic reticulum alters signaling quality. Blood 113, 3568-3576 (2009).
46. Scita, G. & Di Fiore, P. P. The endocytic matrix. Nature 463, 464-473.
47. Muller, P. A. et al. Mutant p53 drives invasion by promoting integrin recycling. Cell 139, 1327-1341 (2009).
48. Grandal, M. V. et al. EGFRvIII escapes down-regulation due to impaired internalization and sorting to lysosomes. Carcinogenesis 28, 1408-1417 (2007). (Pubitemid 47241789)
49. Peschard, P. et al. Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein. Mol. Cell 8, 995-1004 (2001). (Pubitemid 34031802)
50. Honegger, A. M., Schmidt, A., Ullrich, A. & Schlessinger, J. Separate endocytic pathways of kinase-defective and-active EGF receptor mutants expressed in same cells. J. Cell Biol. 110, 1541-1548 (1990). (Pubitemid 20169490)
51. Huang, F., Goh, L. K. & Sorkin, A. EGF receptor ubiquitination is not necessary for its internalization. Proc. Natl Acad. Sci. USA 104, 16904-16909 (2007). (Pubitemid 350210963)
52. Wang, Q., Villeneuve, G. & Wang, Z. Control of epidermal growth factor receptor endocytosis by receptor dimerization, rather than receptor kinase activation. EMBO Rep. 6, 942-948 (2005). (Pubitemid 41521949)
53. Pellinen, T. & Ivaska, J. Integrin Traffic. J. Cell Sci. 119, 3723-3731 (2006). (Pubitemid 44614425)
54. Assaker, G., Ramel, D., Wculek, S. K., Gonzalez-Gaitan, M. & Emery, G. Spatial restriction of receptor tyrosine kinase activity through a polarized endocytic cycle controls border cell migration. Proc. Natl Acad. Sci. USA 107, 22558-22563 (2010).
55. Murphy, J. E., Padilla, B. E., Hasdemir, B., Cottrell, G. S. & Bunnett, N. W. Endosomes: a legitimate platform for the signaling train. Proc. Natl Acad. Sci. USA 106, 17615-17622 (2009).
56. Kong-Beltran, M. et al. Somatic mutations lead to an oncogenic deletion of met in lung cancer. Cancer Res. 66, 283-289 (2006). (Pubitemid 43166034)
57. Cernuda-Morollon, E., Millan, J., Shipman, M., Marelli-Berg, F. M. & Ridley, A. J. Rac activation by the T-cell receptor inhibits T cell migration. PLoS One 5, e12393 (2010).